Earnings Mentions for Johnson & Johnson

Historical counts of specific terms mentioned on earnings calls.

Transcripts Shown
Transcript Type
Overall Yes Rate49%
Next Earnings
Apr 14, 2026
Latest Transcript
Jan 23, 2026
China
Yes
92¢
No
13¢
24/24
Quarters w/ Yes
152Total Mentions
2025 Q4Last Mentioned
Carvykti
Yes
88¢
No
13¢
16/24
Quarters w/ Yes
133Total Mentions
2025 Q4Last Mentioned
Administration
Yes
78¢
No
25¢
9/24
Quarters w/ Yes
20Total Mentions
2025 Q4Last Mentioned
Darzalex Faspro
Yes
22¢
No
85¢
7/24
Quarters w/ Yes
10Total Mentions
2025 Q3Last Mentioned
AI / Artificial Intelligence
Yes
38¢
No
66¢
3/24
Quarters w/ Yes
3Total Mentions
2023 Q4Last Mentioned
You're only seeing data for 5 of 15 words. To see data for the words below, subscribe to our paid plan ($19.99/month).
Europe
Yes
84¢
No
23¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Halda Therapeutics
Yes
66¢
No
45¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Litigation
Yes
89¢
No
24¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Nipocalimab / Lupus
Yes
55¢
No
56¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Ottava
Yes
89¢
No
12¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Procedure
Yes
95¢
No
16¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Rybrevant
Yes
88¢
No
13¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Tariff
Yes
93¢
No
14¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Trufill
Yes
22¢
No
83¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned
Vaccine
Yes
39¢
No
66¢
--
Quarters w/ Yes
--Total Mentions
--Last Mentioned